Horizon Pharma PLC

Horizon Pharma PLC is a leading biopharmaceutical company that is dedicated to developing and bringing to market innovative medicines for rare and rheumatic diseases. With a strong focus on patient-centricity, Horizon Pharma is committed to enhancing the quality of life for individuals living with debilitating conditions by providing access to life-changing therapies. The company's diverse portfolio includes treatments for a range of conditions, including gout, lupus, and thyroid eye disease. Horizon Pharma's ultimate goal is to become a leader in the rare disease space, utilizing its extensive expertise in drug development, commercialization, and patient advocacy to make a significant impact on the lives of patients and their families.